ATE Stock Analysis: Alten | PA
Information Technology Services | PA, France | Market Cap: 2.773m EUR | 12M Return: 14.5% | FR0000071946 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.54M
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Alten S.A. is a France-based engineering and technology consultancy founded in 1988 and headquartered in Boulogne-Billancourt. The company operates across Europe, North America, and Asia-Pacific, serving industrial, telecommunications, and service-sector clients through three core practice areas: technical engineering, research and development, and information systems. Its service portfolio spans mechanical and materials engineering, embedded software, electronics, systems engineering, project management, and a broad range of IT services including cybersecurity, artificial intelligence, cloud infrastructure, and software testing. End markets are highly diversified, covering aerospace/defense/naval, automotive, rail, energy, life sciences, banking/finance/insurance, telecoms, retail, media, and the public sector.
As an IT consulting firm (GICS Sub-Industry: IT Consulting & Other Services), Altens business model is built on deploying skilled engineers and IT consultants on client projects, typically on multi-year assignments. The companys mid-cap status (~$2.74B USD market capitalization) and breadth of sector exposure-particularly its strong presence in regulated, engineering-intensive verticals like aerospace, defense, automotive, and rail-position it as a diversified European engineering services player rather than a niche specialist.
- Automotive R&D demand softens amid slowing EV transition
- Aerospace and defense segment revenue accelerates on NATO spending
- North American IT consulting scale-up via targeted acquisitions
| Net Income: 138.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -1.64 > 1.0 |
| NWC/Revenue: 15.57% < 20% (prev 15.25%; Δ 0.32% < -1%) |
| CFO/TA 0.10 > 3% & CFO 355.4m > Net Income 138.1m |
| Net Debt (228.9m) to EBITDA (447.9m): 0.51 < 3 |
| Current Ratio: 1.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (35.6m) vs 12m ago 1.73% < -2% |
| Gross Margin: 9.01% > 18% (prev 12.78%; Δ -3.77% > 0.5%) |
| Asset Turnover: 113.5% > 50% (prev 114.1%; Δ -0.54% > 0%) |
| Interest Coverage Ratio: 36.48 > 6 (EBIT TTM 346.9m / Interest Expense TTM 9.51m) |
| A: 0.18 (Total Current Assets 1.82b - Total Current Liabilities 1.18b) / Total Assets 3.65b |
| B: 0.03 (Retained Earnings 106.9m / Total Assets 3.65b) |
| C: 0.10 (EBIT TTM 346.9m / Avg Total Assets 3.63b) |
| D: 1.59 (Book Value of Equity 2.24b / Total Liabilities 1.41b) |
| Altman-Z'' = 3.55 = A |
| DSRI: 0.94 (Receivables 1.35b/1.43b, Revenue 4.12b/4.12b) |
| GMI: 1.42 (GM 12.78% / 9.01%) |
| AQI: 1.01 (AQ_t 0.44 / AQ_t-1 0.43) |
| SGI: 1.00 (Revenue 4.12b / 4.12b) |
| TATA: -0.06 (NI 138.1m - CFO 355.4m) / TA 3.65b) |
| Beneish M = -2.70 (Cap -4..+1) = A |
As of October 08, 2026, the stock is trading at EUR 78.65 with a total of 46,614 shares traded. Over the past week, the price has changed by -4.09%, over one month by +11.48%, over three months by +40.57% and over the past year by +14.54%.
Current recommended Stop Loss: 74.50 (which is 5.3% or 1.4 ATR below the current price).
Alten has no consensus analysts rating.
P/E Trailing = 20.1613
P/E Forward = 8.9286
P/S = 0.6725
P/B = 1.1152
P/EG = 1.4311
Revenue TTM = 4.12b EUR
EBIT TTM = 346.9m EUR
EBITDA TTM = 447.9m EUR
Long Term Debt = 8.68m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 125.6m EUR (from shortTermDebt, last quarter)
Debt = 495.6m EUR (from shortLongTermDebtTotal, last quarter) + Leases 222.1m
Net Debt = 228.9m EUR (calculated: Debt 495.6m - CCE 266.7m)
Enterprise Value = 3.00b EUR (2.77b + Debt 495.6m - CCE 266.7m)
Interest Coverage Ratio = 36.48 (Ebit TTM 346.9m / Interest Expense TTM 9.51m)
EV/FCF = 8.74x (Enterprise Value 3.00b / FCF TTM 343.5m)
FCF Yield = 11.44% (FCF TTM 343.5m / Enterprise Value 3.00b)
FCF Margin = 8.33% (FCF TTM 343.5m / Revenue TTM 4.12b)
Net Margin = 3.35% (Net Income TTM 138.1m / Revenue TTM 4.12b)
Gross Margin = 9.01% ((Revenue TTM 4.12b - Cost of Revenue TTM 3.75b) / Revenue TTM)
Gross Margin QoQ = 8.35% (prev 9.70%)
Tobins Q-Ratio = 0.82 (Enterprise Value 3.00b / Total Assets 3.65b)
Interest Expense / Debt = 1.92% (Interest Expense 9.51m / Debt 495.6m)
Taxrate = 41.77% (99.1m / 237.2m)
NOPAT = 202.0m (EBIT 346.9m * (1 - 41.77%))
Current Ratio = 1.54 (Total Current Assets 1.82b / Total Current Liabilities 1.18b)
Debt / Equity = 0.22 (Debt 495.6m / totalStockholderEquity, last quarter 2.24b)
Debt / EBITDA = 0.51 (Net Debt 228.9m / EBITDA 447.9m)
Debt / FCF = 0.67 (Net Debt 228.9m / FCF TTM 343.5m)
Total Stockholder Equity = 2.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.80% (Net Income 138.1m / Total Assets 3.65b)
RoE = 6.23% (Net Income TTM 138.1m / Total Stockholder Equity 2.22b)
RoCE = 15.59% (EBIT 346.9m / Capital Employed (Equity 2.22b + L.T.Debt 8.68m))
RoIC = 8.45% (NOPAT 202.0m / Invested Capital 2.39b)
WACC = 5.61% (E(2.77b)/V(3.27b) * Re(6.41%) + D(495.6m)/V(3.27b) * Rd(1.92%) * (1-Tc(0.42)))
Discount Rate = 6.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 88.97 | Cagr: 1.46%
[DCF] Terminal Value 73.31% ; FCFF base≈365.6m ; Y1≈324.3m ; Y5≈268.0m
[DCF] Fair Price = 119.0 (EV 4.29b - Net Debt 228.9m = Equity 4.06b / Shares 34.1m; r=8.35% [WACC [floored]]; 5y FCF grow -13.84% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 33.11 | Revenue CAGR: 0.23% | SUE: 1.07 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=7.91 | Chg30d=+3.53% | Revisions=+62% | GrowthEPS=+93.5% | GrowthRev=+2.9%
EPS next Year (2027-12-31): EPS=8.61 | Chg30d=-0.01% | Revisions=+62% | GrowthEPS=+8.9% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +77% (up=10, down=0)